GHK-CU 100MG
$100.00
GHK-Cu (Copper Tripeptide-1) is a synthetic copper peptide complex composed of three amino acids (Gly–His–Lys) bound to copper (II), with a molecular weight of approximately 401.9 Da. It is supplied as a blue to blue-green lyophilized powder with ≥99% research-grade purity and a net content of 100 mg.
GHK-Cu is a naturally occurring copper polypeptide found in blood plasma and saliva and is provided strictly for research use only (RUO). It is not intended for human or veterinary use.
Description
Chemical Information
- Chemical Name: GHK-Cu (Copper Tripeptide-1)
- Molecular Formula: C₁₄H₂₄N₆O₄Cu
- Molecular Weight: ~401.9 Da
- Peptide Length: 3 amino acids (Gly–His–Lys) complexed with copper (II)
- Classification: Synthetic copper peptide complex
- Purity: ≥99% (research grade)
- Appearance: Blue to blue-green lyophilized powder
- Net Content: 100 mg
Intended Use
- For research use only (RUO)
- Not for human or veterinary use
GHK-Cu is a natural copper polypeptide found in blood plasma and saliva.
Additional information
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|
Reviews (0)
Related products
CJC-1295 w/ DAC 5MG
CJC-1295 w/ DAC (5 mg) is a synthetic analogue of growth hormone-releasing hormone (GHRH) featuring a Drug Affinity Complex (DAC) that covalently binds serum albumin. This modification extends its half-life up to ~8 days, enabling prolonged and consistent GH release in research settings. It is supplied as a ≥98.5% pure, HPLC-verified lyophilized powder.
Mechanistically, CJC-1295 w/ DAC binds GHRH receptors on anterior pituitary somatotropic cells, activating a G-protein signaling cascade. This triggers adenylyl cyclase → cAMP → PKA activation, leading to CREB phosphorylation. Activated CREB drives GH gene transcription, supporting sustained GH and IGF-1 secretion studies.
DSIP 5MG
Delta Sleep-Inducing Peptide (DSIP) 5MG is a synthetic neuropeptide studied for its role in sleep regulation, particularly slow-wave (deep) sleep. It is supplied as a white to off-white lyophilized powder with ≥99% research-grade purity and a molecular formula of C₃₅H₄₈N₁₀O₁₅.
DSIP has been investigated for its involvement in promoting restorative sleep processes and neuroendocrine balance. Please note that only the 5MG strength is currently available, as the 10MG formulation is no longer being stocked.
FOXO4-DRI
FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide) is a synthetic research peptide composed of 27 D-amino acids with an approximate molecular weight of 5,350–5,400 Da and ≥99% purity. It is supplied as a white to off-white lyophilized powder in 5 mg or 10 mg quantities for laboratory research use.
Researchers use FOXO4-DRI to study cellular aging by examining the selective removal of senescent cells and its impact on tissue repair, regeneration, and longevity pathways through FOXO4–p53 interactions.
GLP-3RT 12MG
GLP-3RT 12MG is a GGG tri-agonist research peptide that activates GLP-1, GIP, and glucagon receptors, enhancing basal metabolism while supporting appetite control and delayed gastric emptying. This multi-receptor activity provides a broader approach to obesity research compared to traditional GLP-1 agonists.
GLP-3RT is a synthetic GLP-based peptide analogue of approximately 30–35 amino acids with a molecular weight of ~3,500–4,200 Da and ≥99% research-grade purity. It is supplied as a white to off-white lyophilized powder in 12 mg vials for in vitro and laboratory research use only.
GLP-3RT 6MG
GLP-3RT is a GGG tri-agonist research peptide that targets GLP-1 and GIP receptors while also uniquely activating the glucagon receptor, distinguishing it from standard GLP-1 agonists. It has been evaluated in Phase 2 clinical studies, including trials focused on obesity and cardiovascular disease, such as TRIUMPH-3.
GLP-3RT is a synthetic GLP-based peptide analogue consisting of approximately 30–35 amino acids, with a molecular weight of ~3,500–4,200 Da and ≥99% HPLC research-grade purity. It is supplied as a white to off-white lyophilized powder in 6 mg quantities and is intended exclusively for in vitro and laboratory research use.
Ipamorelin 10MG
Ipamorelin is a highly selective synthetic growth hormone secretagogue and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It is a pentapeptide with a molecular weight of approximately 711.9 Da and is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity.
Designed for laboratory research, Ipamorelin is used to study selective growth hormone release with minimal off-target activity. It is intended exclusively for in vitro and research applications and is not for human or veterinary use.
Ipamorelin/CJC-1295 (w/o DAC)
Ipamorelin/CJC-1295 (No DAC) 5MG/5MG is a synthetic peptide blend supplied as a white to off-white lyophilized powder for research use. The combination pairs a selective growth hormone secretagogue with a GHRH analogue, providing a stable tool for studying growth hormone signaling and release pathways in laboratory settings.
Ipamorelin supports targeted GH release without significant effects on cortisol or prolactin, while CJC-1295 (No DAC) enables precise evaluation of short-term hormonal responses due to its shorter half-life. Together, this blend allows researchers to investigate natural hormone patterns, metabolic function, and peptide interactions in controlled in vitro research applications.
Melanotan I 10MG
Melanotan 1 (MT-1) is a synthetic tridecapeptide analog of α-melanocyte-stimulating hormone (α-MSH) developed exclusively for scientific research. It is studied for its melanotropic activity, interaction with melanocortin-1 receptors, and its role in pigmentation and melanin synthesis pathways.
In controlled laboratory settings, MT-1 has demonstrated more potent and prolonged melanocyte stimulation than native α-MSH, supporting research into skin pigmentation and photoprotective mechanisms. This compound is strictly for research use only and is not approved for human consumption, therapeutic, or cosmetic applications.
Reviews
There are no reviews yet.